Page 284 - 2020_02-Haematologica-web

L. Martorell et al.
Nonsense suppression by near-cognate tRNAs employs alternative base pairing at codon positions 1 and 3. Proc Natl Acad Sci U S A. 2015;112(10):3038-3043.
16. Vidal F, Farssac E, Altisent C, Puig L, Gallardo D. Rapid hemophilia A molecular diagnosis by a simple DNA sequencing pro- cedure: identification of 14 novel mutations. Thromb Haemost. 2001;85(4):580-583.
17. Jung ME, Ku J-M, Du L, Hu H, Gatti RA. Synthesis and evaluation of compounds that induce readthrough of premature ter- mination codons. Bioorg Med Chem Lett. 2011;21(19):5842-5848.
18. Yu H, Liu X, Huang J, et al. Comparison of readthrough effects of aminoglycosides and PTC124 on rescuing nonsense muta- tions of HERG gene associated with long QT syndrome. Int J Mol Med. 2014; 33(3):729-735.
19. Martorell L, Corrales I, Ramirez L, et al. Molecular characterization of ten F8 splic- ing mutations in RNA isolated from patient’s leucocytes: assessment of in silico prediction tools accuracy. Haemophilia. 2015;21(2):249-257.
20. Yatuv R, Dayan I, Baru M. A modified chro- mogenic assay for the measurement of very low levels of factor VIII activity (FVIII:C). Haemophilia. 2006;12(3):253-257.
21. Bedwell DM, Kaenjak A, Benos DJ, et al. Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line. Nat Med. 1997;3(11):1280-1284.
22. Keeling KM, Brooks DA, Hopwood JJ, et al. Gentamicin-mediated suppression of Hurler syndrome stop mutations restores a low level of alpha-L-iduronidase activity and reduces lysosomal glycosaminoglycan accumulation. Hum Mol Genet. 2001;10(3):291-299.
23. Kumar SR. Industrial production of clotting factors: Challenges of expression, and choice of host cells. Biotechnol J. 2015;10(7):995-1004.
24. Turner NA, Moake JL. Factor VIII Is Synthesized in Human Endothelial Cells, Packaged in Weibel-Palade Bodies and Secreted Bound to ULVWF Strings. PLoS One. 2015;10(10):e0140740.
25. Benhabiles H, Gonzalez-Hilarion S, Amand S, et al. Optimized approach for the identi- fication of highly efficient correctors of nonsense mutations in human diseases. PLoS One. 2017;12(11):e0187930.
26. Hollestelle MJ, Thinnes T, Crain K, et al. Tissue distribution of factor VIII gene expression in vivo--a closer look. Thromb. Haemost. 2001;86(3):855-861.
27. Wion KL, Kelly D, Summerfield JA,
Tuddenham EG, Lawn RM. Distribution of factor VIII mRNA and antigen in human liver and other tissues. Nature. 1985;317(6039):726-729.
28. Olgasi C, Talmon M, Merlin S, et al. Patient-Specific iPSC-Derived Endothelial Cells Provide Long-Term Phenotypic Correction of Hemophilia A. Stem Cell Rep. 2018;11(6):1391-1406.
29. Suzuki Y, Kakisaka K, Matsumoto T, et al. Orthotopic liver transplantation for haemophilia A may not always lead to a phenotypic cure of haemophilia A: A case report. Haemophilia. 2018;24(6):e420-e422.
30. Branchini A, Ferrarese M, Campioni M, et al. Specific factor IX mRNA and protein features favor drug-induced readthrough over recurrent nonsense mutations. Blood. 2017;129(16):2303-2307.
31. Baradaran-Heravi A, Balgi AD, Zimmerman C, et al. Novel small mole- cules potentiate premature termination codon readthrough by aminoglycosides. Nucleic Acids Res. 2016;44(14):6583-6598.
32. Schmittgen TD, Zakrajsek BA, Mills AG, et al. Quantitative reverse transcription-poly- merase chain reaction to study mRNA decay: comparison of endpoint and real- time methods. Anal Biochem. 2000; 285(2):194-204.
518
haematologica | 2020; 105(2)